Anteris Technologies Global/$AVR
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Anteris Technologies Global
Anteris Technologies Global Corp is a structural heart company focused on advancing cardiac care through science-driven innovations aimed at restoring heart valve patients to healthy function. Its key product, the DurAVR Transcatheter Heart Valve (THV), was designed in partnership with interventional cardiologists and cardiac surgeons to treat Aortic Stenosis, a potentially life-threatening condition caused by narrowing of the aortic valve. The balloon-expandable DurAVR THV is a biomimetic valve designed to mimic the performance of a healthy human aortic valve and replicate normal aortic blood flow. The company operates in United States, Germany, Australia, Switzerland, and Sweden, with the majority of its revenue generated from the United States.
Ticker
$AVR
Sector
Primary listing
Employees
174
Headquarters
Toowong, Australia
Website
AVR Metrics
BasicAdvanced
$903m
-
-$1.96
0.59
-
Price and volume
Market cap
$903m
Beta
0.59
52-week high
$10.14
52-week low
$2.85
Average daily volume
1.2m
Financial strength
Current ratio
20.934
Quick ratio
20.661
Long term debt to equity
0.871
Total debt to equity
1.342
Interest coverage (TTM)
-1,298.93%
Profitability
EBITDA (TTM)
-94.434
Gross margin (TTM)
74.28%
Net profit margin (TTM)
-5,148.78%
Operating margin (TTM)
-5,192.92%
Effective tax rate (TTM)
-0.52%
Revenue per employee (TTM)
$10,000
Management effectiveness
Return on assets (TTM)
-33.99%
Return on equity (TTM)
-59.21%
Valuation
Price to revenue (TTM)
247.647
Price to book
4.59
Price to tangible book (TTM)
4.59
Price to free cash flow (TTM)
-5.276
Free cash flow yield (TTM)
-18.95%
Free cash flow per share (TTM)
-1.785
Growth
Revenue change (TTM)
-25.75%
Earnings per share change (TTM)
-40.66%
3-year revenue growth (CAGR)
-17.67%
3-year earnings per share growth (CAGR)
-6.29%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs